Relapsed Multiple Myeloma
Showing 1 - 25 of 25
Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)
Not yet recruiting
- Refractory Multiple Myeloma
- Relapsed Multiple Myeloma
- Iberdomide
- +6 more
-
Miami, FloridaUniversity of Miami
May 31, 2023
Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,
Recruiting
- Refractory Multiple Myeloma
- Relapsed Multiple Myeloma
- Manufactured Anti-BCMA CAR-T cells
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Carfilzomib)
Completed
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Dexamethasone
- +2 more
-
Boca Raton, Florida
- +112 more
Sep 9, 2022
Relapsed Multiple Myeloma Trial in Spain (Belantamab mafodotin, Carfilzomib, Dexamethasone)
Recruiting
- Relapsed Multiple Myeloma
- Belantamab mafodotin
- +2 more
-
Badalona, Spain
- +14 more
Sep 5, 2022
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (REGN5459)
Active, not recruiting
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
-
Indianapolis, Indiana
- +6 more
Aug 16, 2022
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Rapid Infusion Isatuximab)
Withdrawn
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Rapid Infusion Isatuximab
- (no location specified)
Jul 3, 2022
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))
Withdrawn
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Elotuzumab, Selinexor, and Dexamethasone (ESd)
- (no location specified)
Apr 27, 2022
Relapsed Multiple Myeloma Trial in Italy (Isatuximab-dexamethasone)
Active, not recruiting
- Relapsed Multiple Myeloma
-
Ancona, Italy
- +14 more
Mar 24, 2022
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)
Completed
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Ixazomib
- +3 more
-
Little Rock, Arkansas
- +23 more
Feb 24, 2022
Relapsed Multiple Myeloma in France in Context of Carfilzomib
Completed
- Relapsed Multiple Myeloma
-
Le Mans, FranceCentre Hospitalier Du Mans
Mar 8, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (ION251)
Recruiting
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
-
Birmingham, Alabama
- +11 more
Oct 13, 2021
Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Boston, Danvers, Newton (Nivolumab, Ixazomib, Dexamethasone)
Active, not recruiting
- Relapsed Multiple Myeloma
- Refractory Multiple Myeloma
- Nivolumab
- +3 more
-
Boston, Massachusetts
- +2 more
May 14, 2021
Non-interventional Study on Salvage Auto in Relapsed Myeloma
Completed
- Relapsed Multiple Myeloma
-
Paris, FranceHématologie Clinique, Hôpital Saint Antoine
Jan 19, 2021
Relapsed Multiple Myeloma Trial in Worldwide (Dexamethasone, Lenalidomide, Carfilzomib)
Completed
- Relapsed Multiple Myeloma
- Dexamethasone
- +2 more
-
Scottsdale, Arizona
- +126 more
Dec 21, 2018
Relapsed Multiple Myeloma Trial in Odense (peptides derived from antiapoptotic proteins)
Completed
- Relapsed Multiple Myeloma
- peptides derived from antiapoptotic proteins
-
Odense, DenmarkDepartment of Haematology, Odense University Hospital
Aug 30, 2018
Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)
Unknown status
- Hematologic Cancer
- +8 more
- GLIDE
-
Montreal, Quebec, CanadaCIUSSS d l'Est-de-l'Île-de-Montréal
Dec 4, 2017
Relapsed Multiple Myeloma Trial in Canada, United States (Carfilzomib, Lenalidomide, Dexamethasone)
Completed
- Relapsed Multiple Myeloma
- Carfilzomib
- +2 more
-
Long Beach, California
- +11 more
Apr 28, 2017
Relapsed Multiple Myeloma, End-stage Renal Disease Trial in Australia, Canada, United States (Carfilzomib)
Completed
- Relapsed Multiple Myeloma
- End-stage Renal Disease
-
Detroit, Michigan
- +12 more
Apr 28, 2017
Relapsed Multiple Myeloma Trial in Iowa City (ATRA, Celecoxib, Itraconazole)
Completed
- Relapsed Multiple Myeloma
- ATRA
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Feb 20, 2017
Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Multiple Myeloma Trial in United States (Bortezomib, CC-5013)
Completed
- Refractory Multiple Myeloma
- +2 more
-
Tampa, Florida
- +5 more
Jan 21, 2016
Relapsed Multiple Myeloma, Plateau Phase Multiple Myeloma Trial in Boston, Rochester (2-methoxyestradiol)
Completed
- Relapsed Multiple Myeloma
- Plateau Phase Multiple Myeloma
-
Boston, Massachusetts
- +1 more
Feb 25, 2009